Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | BRD2 | P25440 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10768662 | 0.98 | PIK3CD (0.34) | PIK3CDCA1CA2CA4KMT2A | |
| SCHEMBL18469064 | 0.87 | RAB9A (0.35) | PIK3CDCA1CA2CA4KMT2A | |
| SCHEMBL20041080 | 0.86 | CA1 (0.41) | PIK3CDCA1CA2CA4KMT2A | |
| SCHEMBL18684017 | 0.77 | CA1 (0.32) | CA1CA2CA4KMT2ASRD5A1 | |
| SCHEMBL13030821 | 0.77 | CA1 (0.32) | CA1CA2CA4KMT2ASRD5A1 | |
| SCHEMBL14075291 | 0.76 | CA1 (0.35) | CA1CA2CA4KMT2ASRD5A1 | |
| SCHEMBL10182573 | 0.75 | — | — | |
| SCHEMBL2021592 | 0.75 | — | — | |
| SCHEMBL4181392 | 0.75 | — | — | |
| SCHEMBL12835385 | 0.74 | PIK3CD (0.34) | PIK3CDCA1CA2CA4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021259309-A1 | GLP-1 RECEPTOR AGONIST, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 广州市恒诺康医药科技有限公司 | 2021-12-30 | — | — | WO | disclosed |
| US-10973910-B1 | Neoglycoconjugates as vaccines and therapeutic tools | KORANEX CAPITAL (CA) | 2021-04-13 | — | — | US | disclosed |
| US-10610576-B2 | Precision glycoconjugates as therapeutic tools | KORANEX CAPITAL (CA) | 2020-04-07 | — | — | US | disclosed |
| US-20190290746-A1 | PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS | KORANEX CAPITAL (CA) | 2019-09-26 | — | — | US | disclosed |
| WO-2019043214-A1 | GLUTARIMIDE | F. HOFFMANN-LA ROCHE AG (CH) | 2019-03-07 | — | — | WO | disclosed |
| US-9399730-B2 | Wavelength conversion material as encapsulate for solar module systems to enhance solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-26 | — | — | US | disclosed |
| US-9394479-B2 | Wavelength conversion film having pressure sensitive adhesive layer to enhance solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9382424-B2 | Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency | NITTO DENKO CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| US-20160108310-A1 | WAVELENGTH CONVERSION FILMS WITH MULTIPLE PHOTOSTABLE ORGANIC CHROMOPHORES | NITTO DENKO CORPORATION (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20150041052-A1 | WAVELENGTH CONVERSION LAYER ON A GLASS PLATE TO ENHANCE SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| US-20150041042-A1 | PRESSURE SENSITIVE ADHESIVE TYPE OF WAVELENGTH CONVERSION TAPE FOR ENHANCING SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2015-02-12 | — | — | US | disclosed |
| US-20140311566-A1 | MICROSTRUCTURED WAVELENGTH CONVERSION FILMS FOR ENHANCED SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2014-10-23 | — | — | US | disclosed |
| US-20130139868-A1 | WAVELENGTH CONVERSION MATERIAL AS ENCAPSULATE FOR SOLAR MODULE SYSTEMS TO ENHANCE SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| US-20130089946-A1 | WAVELENGTH CONVERSION FILM HAVING PRESSURE SENSITIVE ADHESIVE LAYER TO ENHANCE SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | NITTO DENKO CORPORATION (JP) | 2013-03-28 | — | — | US | disclosed |
| US-20110104186-A1 | Small molecule immunopotentiators and assays for their detection | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2011-05-05 | — | — | US | disclosed |
| EP-0564358-B1 | 3-aminochromane spiro derivatives, processes for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1998-11-04 | — | — | EP | disclosed |
| EP-0564358-A1 | 3-aminochromane spiro derivatives, processes for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1993-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10610576-B2 | Precision glycoconjugates as therapeutic tools | STT3B, STT3A, SIGLEC7 | PIK3CD 4634/4885CA1 623/4885CA2 1131/4885 |
| US-20130074927-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR ENHANCED SOLAR HARVESTING EFFICIENCY | SUN2, NES, CRY1 | PIK3CD 3557/4885CA1 3396/4885CA2 2060/4885 |
| US-20190290746-A1 | PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS | STT3B, STT3A, SIGLEC7 | PIK3CD 4634/4885CA1 623/4885CA2 1131/4885 |
| US-20110104186-A1 | Small molecule immunopotentiators and assays for their detection | ICOS, CD14, MAVS | PIK3CD 900/4885CA1 3433/4885CA2 1075/4885 |
| US-10973910-B1 | Neoglycoconjugates as vaccines and therapeutic tools | GNE, B3GNT2, KRTCAP2 | PIK3CD 4710/4885CA1 1594/4885CA2 1700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.